Previous studies have reported the involvement of RUNX3 promoter methylation in many cancers, including colorectal [12,13], gastric [14], bladder [15], breast [16], lung [17], oral [18], and nasopharyngeal cancers [19]. This evidence concerns the gene RUNX3 and cancer.